Colgate-Palmolive (NYSE:CL) Stock: Insider Panagiotis Tsourapas Sells 19,938 Shares

Posted by Francis Steltz on Nov 8th, 2026

Colgate-Palmolive Company (NYSE:CL – Get Free Report) COO Panagiotis Tsourapas sold 19,938 shares of the firm’s stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $98.74, for a total transaction of $1,968,678.12. Following the transaction, the chief operating officer directly owned 9,111 shares in the company, valued at $899,620.14. The trade was a 68.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Panagiotis Tsourapas also recently made the following trade(s):

On Monday, August 24th, Panagiotis Tsourapas sold 10,000 shares of Colgate-Palmolive stock. The shares were sold at an average price of $92.05, for a total transaction of $920,500.00.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $96.61 on Friday. Colgate-Palmolive Company has a one year low of $75.96 and a one year high of $101.18. The stock has a market capitalization of $76.80 billion, a price-to-earnings ratio of 37.89, a PEG ratio of 4.38 and a beta of 0.31. The company has a 50-day simple moving average of $90.12 and a 200-day simple moving average of $89.97. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.30 and a current ratio of 0.96.

Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings results on Friday, October 30th. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.34 billion. During the same quarter last year, the company posted $0.91 earnings per share. The business’s revenue was up 4.6% on a year-over-year basis. On average, analysts predict that Colgate-Palmolive Company will post 3.92 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 annualized dividend and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio is currently 83.14%.

Analyst Ratings Changes

CL has been the topic of several analyst reports. Citigroup lifted their target price on Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Evercore boosted their target price on Colgate-Palmolive from $100.00 to $101.00 and gave the company an “outperform” rating in a report on Thursday, October 8th. Weiss Ratings cut Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Bank of America increased their price target on Colgate-Palmolive from $100.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, November 2nd. Finally, UBS Group lifted their price objective on shares of Colgate-Palmolive from $106.00 to $112.00 and gave the company a “buy” rating in a research report on Monday, November 2nd. Thirteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $101.22.

Get Our Latest Analysis on Colgate-Palmolive

Institutional Investors Weigh In On Colgate-Palmolive

A number of hedge funds have recently added to or reduced their stakes in CL. Diversified Trust Co lifted its position in Colgate-Palmolive by 2.5% in the third quarter. Diversified Trust Co now owns 111,746 shares of the company’s stock valued at $9,534,000 after purchasing an additional 2,758 shares during the period. Vista Capital Partners Inc. purchased a new stake in Colgate-Palmolive in the 3rd quarter valued at approximately $498,000. Hamel Associates Inc. increased its position in Colgate-Palmolive by 524.3% during the 3rd quarter. Hamel Associates Inc. now owns 29,281 shares of the company’s stock worth $2,498,000 after purchasing an additional 24,591 shares during the period. Moors & Cabot Inc. increased its position in Colgate-Palmolive by 1.0% during the 3rd quarter. Moors & Cabot Inc. now owns 42,266 shares of the company’s stock worth $3,606,000 after purchasing an additional 409 shares during the period. Finally, Money Concepts Capital Corp raised its stake in shares of Colgate-Palmolive by 2.6% during the 3rd quarter. Money Concepts Capital Corp now owns 47,726 shares of the company’s stock worth $4,072,000 after buying an additional 1,220 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food.

The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world.

Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.